Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07216573 · ClinicalTrials.gov registry record · NA

The Continuity Study

A NA study, sponsored by Becton, Dickinson and Company.

Recruiting
Registry status
NA
Development phase
188
Enrollment target

NCT07216573 is a NA study that is actively recruiting participants, run by Becton, Dickinson and Company. The registered enrollment target is 188 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07216573, a NA study, is actively recruiting participants, sponsored by Becton, Dickinson and Company.

RECRUITING
Registry status
NA
Development phase
188 participants
Enrollment target

Study Summary

A before and after interventional cohort study comparing intermittent blood pressure measurement using the oscillometric arm cuff to continuous noninvasive blood pressure (cNIBP) measurement using the VitaWave finger cuffs in subjects undergoing elective surgery in an outpatient setting.

Interventions

  • DEVICE HemoSphere Vita Monitor with VitaWave or VitaWave Plus Finger Cuff Adult, and ForeSight Large Sensors

Trial Details

FieldValue
Enrollment Target 188 participants
Start Date 2026-05-07
Est. Completion 2027-02
Phase NA

Sponsor

Becton, Dickinson and Company

33 total trials

What the Registry Record Tells You About NCT07216573

The ClinicalTrials.gov registry entry for NCT07216573 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which HemoSphere Vita Monitor with VitaWave or VitaWave Plus Finger Cuff Adult, and ForeSight Large Sensors is the first listed.

NCT07216573 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07216573 about?

NCT07216573 is a clinical study titled "The Continuity Study". A before and after interventional cohort study comparing intermittent blood pressure measurement using the oscillometric arm cuff to continuous noninvasive blood pressure (cNIBP) measurement using the VitaWave finger cuffs in subjects undergoing elective surgery in an outpatient setting.

What is the current status of trial NCT07216573?

This trial is currently recruiting. It is a NA study. The enrollment target is 188 participants. The study started on 2026-05-07. Estimated completion is 2027-02.

What interventions are being tested in trial NCT07216573?

The interventions under investigation include: HemoSphere Vita Monitor with VitaWave or VitaWave Plus Finger Cuff Adult, and ForeSight Large Sensors (DEVICE).

Who is sponsoring clinical trial NCT07216573?

This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.